The cause-effect relationship between RRAS2 overexpression and CLL is reinforced by the finding that a SNP in the 3’UTR of the RRAS2 mRNA is associated with more lymphocytosis, fewer platelets, chromosomal aberrations and with full-blown disease. The gene discussed is RRAS2; the disease is B-cell chronic lymphocytic leukemia.